beta-3 adrenergic receptor agonists (Asahi Kasei)

N/A

Report date: 2025/03/14 20:00:48
NME

Base Information

Drug Namebeta-3 adrenergic receptor agonists (Asahi Kasei)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionBeta-3 adrenergic receptor agonists
TargetsBeta-3 adrenergic receptor
Therapy Area/IndicationsUrinary Bladder, Overactive
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryJapan
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesAsahi Kasei Pharma Corp
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAsahi Kasei Pharma Corp
Active IndicationsN/A
Inactive IndicationsUrinary Bladder, Overactive

Other Information

ATC CodeN/A
Related LinksN/A